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Summary
Aim. — To evaluate the information provided by echocardiography and cardiac catheterization
in patients with partial cavopulmonary connection (PCPC) with or without additional pulmonary
blood ﬂow (PBF) in whom total cavopulmonary connection (TCPC) was planned.
Methods. — We retrospectively evaluated the results provided by echocardiography and cardiac
catheterization in 110 consecutive patients with PCPC (35 with isolated PCPC, 38 with associated
antegrade PBF, 37 with associated retrograde PBF) in whom TCPC was planned.
Results. — Eight patients had superior vena cava syndrome; all others suffered from cyanosis and
fatigue. Pulmonary artery size could be determined in 54% of patients without additional PBF, in
47% of those with associated retrograde PBF and in 68% of those with associated PBF (p = 0.20).
Concomitant clinical signs of increased central venous pressure and echocardiographic signs of
ventricular dysfunction and/or hypoplastic pulmonary arteries identiﬁed four patients in whom
TCPC was not low-risk. PAP exceeding 16mmHg was found in 9% of patients without and 16%
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DCPP chez lesquels une DCPT est envisagée, surtout chez ceux ayant un ﬂux pulmonaire addi-
tionnel. Seulement cet examen permet d’identiﬁer les patients à risque et de traiter des lésions
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bbreviations
V atrioventricular
T Blalock-Taussig
T computed tomography
AP pulmonary pressure
BF pulmonary blood ﬂow
CPC partial cavopulmonary connection
CPC total cavopulmonary connection
ackground
CPC usually precedes conversion to TCPC in patients with
ingle ventricle physiology. PCPC can be the ﬁrst palliation
n patients with low PAP, but it is often preceded by BT shunt
n patients with duct-dependent physiology or by pulmonary
anding in those with pulmonary overﬂow. PCPC can be the
nly source of blood to the lungs, allowing the patient to
each the age of 2 to 3 years with moderate cyanosis at
est. This is the age at which TCPC is performed in most
entres, generally by using an extracardiac conduit [1,2].
hen TCPC is planned at an older age [3], an additional
u
b
t
w
ts droits réservés.
ative or surgically created source of PBF can be left in
lace at the time of PCPC. This strategy is often adopted
y some cardiac surgeons of the French school [4]. TCPC is
enerally preceded by cardiac catheterization, intended to
easure mean PAP, to assess pulmonary artery size and to
reat possible associated anomalies.
For low-risk TCPC, 10 inclusion criteria were initially
roposed [5], but some of these have been considered
verly restrictive [6,7]. At present, the criteria for low-risk
CPC are mean PAP not exceeding 14 to 16mmHg, normal
ulmonary artery size [3,8] and absence of ventricular dys-
unction and/or severe incompetence of AV valve(s) [3,8,9].
he most useful index to measure pulmonary artery size
s the Nakata index [10]. The accepted Nakata index for
atients scheduled for TCPC is at least 200mm2/m2 [3,8,9].
The aim of this study was to evaluate retrospectively
atients with PCPC with or without additional PBF who304 H.O. Ba et al.
of those with associated PBF (p = 0.38). The Nakata index was higher in patients with associ-
ated antegrade PBF than in those without associated PBF (p = 0.004) or in those with associated
retrograde PBF (p = 0.002). Of the 16 patients who needed concomitant interventional catheter-
ization, 10 had associated retrograde PBF (p < 0.05). In 11 patients (nine with and two without
additional PBF), TCPC was contraindicated.
Conclusion. — Cardiac catheterization is still necessary before TCPC, mostly in patients with
additional PBF, to identify those at risk and those needing interventional catheterization.
© 2009 Elsevier Masson SAS. All rights reserved.
MOTS CLÉS
Cardiopathie
congénitale ;
Pédiatrie ;
Ventricule unique ;
Cyanose
Résumé
Objectif. — Le but de cet étude était d’évaluer si les informations cliniques et échocar-
diographiques obtenues chez les enfants avec un ventricule unique et une dérivation
cavopulmonaire partielle (DCPP) avec ou sans ﬂux pulmonaire additionnel étaient sufﬁsantes
pour contre-indiquer une dérivation cavopulmonaire totale (DCPT).
Méthodes. — Nous avons évalué rétrospectivement les résultats de l’écographie cardiaque et du
cathétérisme cardiaque faits en vue d’une DCPT chez 110 enfants consécutifs ayant une DCPP
isolée (n = 35) ou associée à un ﬂux pulmonaire antérograde (n = 38) ou rétrograde (n = 37).
Résultats. — Huit patients avaient un syndrome de la veine cave supérieure, les autres étaient
cyanosés et essoufﬂés au repos ou à l’effort. La taille des artères pulmonaires a pu être
analysée chez 54% des patients sans ﬂux pulmonaire additionnel, chez 47% de ceux avec
un ﬂux additionnel rétrograde et chez 68% de ceux avec un ﬂux additionnel antérograde
(p = 0,20). La coexistence des signes cliniques de pression veineuse centrale augmentée et de
signes échographiques de dysfonction ventriculaire et/ou d’hypoplasie des artères pulmonaires
a pu identiﬁer quatre patients à risque. Nous avons retrouvé une pression pulmonaire moyenne
supérieure à 16mmHg chez 9% des patients sans ﬂux pulmonaire additionnel et chez 16% de ceux
avec un ﬂux pulmonaire associé (p = 0,38). L’index de Nakata était plus élevé chez les patients
avec un ﬂux antérograde associé, par rapport à ceux sans ﬂux associé (p = 0,004) ou avec un
ﬂux rétrograde associé (p = 0,002). Seize patients ont bénéﬁcié d’un cathétérisme interven-
tionnel. Parmi ces patients, dix avaient un ﬂux pulmonaire rétrograde associé (p < 0,05). Chez
11 patients (neuf avec et deux sans ﬂux pulmonaire additionnel), les données hémodynamiques
et angiographiques ont contre-indiqué une DCPT.
Conclusion. — Le cathétérisme cardiaque est un examen nécessaire chez les patients avec unenderwent echocardiography and cardiac catheterization
efore TCPC over a 10-year period. We had two main objec-
ives: to determine whether clinical information associated
ith echocardiographic ﬁndings could have been sufﬁcient
o identify low-risk candidates for TCPC and to identify the
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proportion of patients in whom cardiac catheterization was
necessary either to contraindicate TCPC and/or to treat
associated anomalies.
Methods
Study population
From January 1998 to September 2007, 110 patients with
PCPC underwent scheduled cardiac catheterization before
TCPC. Consecutive paediatric patients (less than 18 years)
with PCPC with or without additional PBF in whom TCPC was
planned were included. Patients were excluded for severe
ventricular dysfunction associated with severe incompe-
tence of the AV valve(s) needing medical treatment, hepatic
disease, interrupted inferior vena cava and chromosomal
diseases apart from trisomy 21.
We identiﬁed three groups of patients:
• isolated PCPC (n = 35);
• PCPC with associated retrograde ﬂow (n = 37);
• PCPC with associated antegrade ﬂow (n = 38).
Clinical, echocardiographic and
haemodynamic evaluation
Hospital records and echocardiographic, catheterization and
surgical ﬁles were reviewed. Complications occurring during
catheterization and/or surgery were sought and recorded.
All children underwent clinical and echocardiographic
assessments and cardiac catheterization at Necker—Enfants-
Malades. The study was approved by the institutional review
committee. Parents gave consent to catheterization and to
inclusion into the study.
The following clinical ﬁndings were noted: fatigue,
superior vena cava syndrome (deﬁned as facial and neck
swelling), hepatomegaly and systemic oxygen saturation at
rest. The echocardiographic ﬁndings recorded were:
• systolic dysfunction of the single ventricle, deﬁned as
ejection fraction of less than 50% [9];
• increased ﬁlling pressure, deﬁned as inferior vena cava
depression during inspiration of less than 50%;
• moderate to severe incompetence of AV valve(s)
[8,9];
• visualization and size of pulmonary arteries.
The Simpson technique was used to calculate ejection
fraction, although we are aware that this method has limited
value for patients with a single ventricle.
All echocardiographic evaluations were performed using
a GE Vingmed Vivid 7 ultrasound system connected to a 5-
MHz probe (General Electrics, Fairﬁeld, Connecticut; USA).
Catheterization was performed, according to the presence
of forward ﬂow to the lungs, via the femoral vein or
the internal jugular vein. Heparin at a dose of 50UI/kg
or 100UI/kg was administered when aortography was per-
formed. Pulmonary angiography was performed by injecting
1mL/kg of contrast medium. The diameters of the right
and left pulmonary arteries were measured immediately
proximal to their ﬁrst branches and used to calculate cross-
sectional areas. The combined pulmonary artery areas were
expressed as the Nakata index as previously described [10].
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uring the study period, non-invasive imaging of pulmonary
rteries was not performed systematically.
TCPC was contraindicated when both PAP was more than
6mmHg and the Nakata index was less than 200mm2/m2,
n the absence of additional ﬂow; when PAP remained more
han 16mmHg after test occlusion of any additional ﬂow;
r when ventricular dysfunction with or without incom-
etence of AV valve(s) was accompanied by increased
trial or pulmonary wedge pressure despite medical treat-
ent.
tatistical analyses
esults are expressed as numerical values and percentages
or categorical variables and as mean± standard deviation
SD) for continuous variables.
Comparisons between the three groups (isolated PCPC,
CPC with associated retrograde PBF and PCPC with asso-
iated antegrade PBF) were performed using Anova for
ontinuous variables and the 2 test or Fisher’s exact test
or categorical data. Comparisons of continuous variables
etween patients with and without additional PBF were
erformed with Student t-test, whereas comparisons of cat-
gorical variables were performed with the Pearson 2 test
r Fisher’s exact test, as appropriate.
All statistical analyses were performed using the R
oftware package (http://cran.r-project.org/). Statistical
igniﬁcance was considered as a p-value of less than 0.05.
ll tests were two-sided.
esults
revious surgical treatment and associated sources of pul-
onary ﬂow are illustrated in Table 1.
linical signs
linical signs and echocardiographic ﬁndings are described
n Table 2. Mean age at catheterization was 8.3± 4.2 years
range 1.6 to 17.9 years). Patients with retrograde PBF
ere signiﬁcantly older than those without additional ﬂow
9.5± 4.3 years versus 7± 4.3 years, p = 0.014). Mean sys-
emic oxygen saturation and the presence of fatigue were
imilar in patients with and without additional PBF. Of the
ight patients with superior vena cava syndrome, six (75%)
ad additional PBF. Hepatomegaly was found in seven (9%)
atients with additional PBF and in no patient without addi-
ional PBF (p = 0.09).
chocardiographic ﬁndings
ulmonary artery size could be analysed, as expected, in
nly 54% of patients without additional PBF, in 47% of those
ith associated retrograde PBF and in 68% of those with
ssociated antegrade PBF (p = 0.20). Moderate to severe
ncompetence of AV valve(s) was found in nine patients with
dditional PBF (12%) and in one patient without additional
BF (3%) (p = 0.16). Ventricular dysfunction was found in
3 patients with additional PBF (17%) and in four without
dditional PBF (11%) (p = 0.42).
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Table 1 Previous surgery and additional pulmonary blood ﬂow in the three groups of patients.
First surgery Second surgery Associated source of PBF
Isolated PCPC (n = 35) 12 BT shunt 1 PA reconstruction N/A
3 Norwood
2 PB
Associated retrograde PBF
(n = 37)a
26 BT shunt 2 PA reconstruction 26 BT shunt, 6
AVF, 10 PDA4 Norwood 6 AVF
1 PB 1 BT shunt
Associated antegrade PBF
(n = 38)
2 Norwood-Sano 2 conduits single ventricle
to PA, 17 PB, 19 native
pulmonary outﬂow
15 pulmonary banding 1 PA reconstruction
3 PB and aortic coarctation repair 1 PA reconstruction
AVF: arteriovenous ﬁstula; BT: Blalock-Taussig; N/A: not applicable; PA: pulmonary arteries; PB: pulmonary banding; PBF: pulmonary
blood ﬂow; PCBC: partial cavopulmonary connection; PDA: patent ductus arteriosus.
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ta In ﬁve patients, PDA and BT or AVF coexisted.
Of eight patients with superior vena cava syndrome, two
ad hepatomegaly, seven had moderate to severe incompe-
ence of AV valve(s) and three had ventricular dysfunction.
ulmonary artery size could be analysed in only four patients
nd was deﬁned as normal in three and small (less than −2
-values) in one.
Coexistence of clinical signs of increased central venous
ressure and echocardiographic signs of ventricular dysfunc-
ion and/or hypoplastic pulmonary arteries identiﬁed four
atients in whom TCPC would not be low-risk.
ardiac catheterizationaemodynamic characteristics are shown in Table 3.
ean PAP was 12.3± 4.3mmHg, mean aortic pressure was
0.3± 13.7mmHg and mean pulmonary artery size (Nakata
ndex) was 209.9± 42.7mm2/m2. Although PAP exceeding
6mmHg was found in 9% of patients without and in 16% of
r
t
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c
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Table 2 Clinical and echocardiographic characteristic of pati
Isolated PCPC
(n = 35)
Associated retrograde
PBF (n = 37)
Sex (F/M) 14/21 17/20
Age, years
(mean± SD)
7± 4.3 9.5± 4.3
Systemic oxygen
saturation
(mean± SD)
81± 5.9 81± 6.8
Fatigue, n (%) 19 (54) 16 (43)
Superior vena cava
syndrome, n (%)
2 (6) 4 (11)
Hepatomegaly, n (%) 0 3 (8)
Visualization of PA,
n (%)
19 (54) 18 (47)
Incompetence of AV
valve(s), n (%)
1 (3) 5 (14)
Ventricular
dysfunction, n (%)
4 (11) 6 (16)
AV: arteriovenous; PA: pulmonary arteries; PBF: pulmonary blood ﬂow;hose with associated PBF, this difference was not statisti-
ally signiﬁcant (p = 0.38). Mean aortic pressure was higher
n patients with associated retrograde ﬂow, but not signiﬁ-
antly so.
Nakata index was signiﬁcantly higher in patients with
ssociated antegrade ﬂow than in those without associated
ow (p = 0.004) or in those with associated retrograde ﬂow
p = 0.002, Fig. 1). Of eight patients with normal Nakata
ndex and PAP exceeding 16mmHg, one had isolated PCPC,
ne had associated retrograde ﬂow and six had associated
ntegrade ﬂow.
There were 16 associated procedures: one BT emboliza-
ion, 10 patent ductus arteriosus embolizations, one arte-
iovenous ﬁstula embolization, two dilatations of recoarc-
ation, one pulmonary artery dilatation and one dilatation
nd stenting of an occluded innominate vein. Interventional
atheterization was more often performed in patients with
etrograde PBF (27%) than in those with antegrade PBF (8%)
ents.
Associated antegrade
PBF (n = 38)
Group
1,2,3 (p)
Isolated PCPC vs
additional PBF (p)
21/17 0.41 0.29
8.3± 3.9 0.048 0.03
82± 6.7 0.88 0.97
19 (50) 0.63 0.45
2 (5) 0.65 1
4 (11) 0.17 0.09
26 (68) 0.20 0.67
4 (11) 0.31 0.16
7 (18) 0.70 0.42
PCPC: partial cavopulmonary connection.
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Table 3 Haemodynamic characteristics of patients.
Isolated PCPC
(n = 35)
Associated retrograde
PBF (n = 37)
Associated antegrade
PBF (n = 38)
Group
1,2,3 (p)
Isolated PCPC vs
additional PBF (p)
PAP, mmHg (mean± SD) 11.5± 3.7 12.1± 4.0 13.3± 5.0 0.20 0.16
PAP > 16mmHg, n (%) 3 (9) 6 (16) 6 (16) 0.61 0.38
Aortic pressure, mmHg
(mean± SD)
66.7± 12.7 73.7± 14.2 70.2± 13.7 0.10 0.06
Interventional
catheterization, n (%)
3 (9) 10 (27) 3 (8) 0.03 0.22
Contraindication to
TCPC, n (%)
2 (6) 6 (16) 2 (5) 0.27 0.50
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cPAP: pulmonary pressure; PBF: pulmonary blood ﬂow; PCPC: parti
or isolated PCPC (9%) (p = 0.03). There were no immediate
or late complications of cardiac catheterization.
In accordance with the results of haemodynamic evalu-
ation, TCPC was contraindicated in 11 patients (two with
isolated PCPC and nine with additional PBF, p = 0.50).
Reasons for contraindication were: coexistence of PAP
exceeding 16mmHg and Nakata index less than 200 in six
patients, ventricular dysfunction in four and lack of normal-
ization of PAP after test occlusion of pulmonary banding in
one. Therefore, haemodynamic investigation conﬁrmed that
clinical and echocardiographic evaluation identiﬁed the four
patients in whom TCPC was not considered low-risk because
of ventricular dysfunction, but was necessary to identify the
remaining seven patients.Follow-up
Eighty-four patients had TCPC at a median of 62 days after
cardiac catheterization (2 days to 1.7 years); in 73, a fenes-
Figure 1. Pulmonary artery size (Nakata index) in patients with
and without additional pulmonary blood ﬂow.
PCPC: partial cavopulmonary connection.
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populmonary connection; TCPC: total cavopulmonary connection.
ration was created. Thirty-eight patients had complications
23 had effusions, four arrhythmias, four cerebral embolism,
our sepsis, two ventricular dysfunction, two bleeding).
here were two perioperative deaths due to haemor-
hage (n = 1) and ventricular dysfunction (n = 1). One of
he eight patients with superior vena cava syndrome had
CPC, complicated by pleural effusion. Neither preopera-
ive PAP nor Nakata index were predictors of postoperative
omplications and/or death.
At the time of writing, 15 patients (one with superior
ena cava syndrome) are on a waiting list for TCPC. Of
our patients in whom TCPC was contraindicated because
f ventricular dysfunction, two underwent cardiac trans-
lantation. There were three deaths, 2 to 4.6 years after
atheterization, but these were not causally related to
atheterization. Six patients are living with PCPC and addi-
ional PBF, without major systemic desaturation or severe
entricular dysfunction.
iscussion
his study shows that cardiac catheterization was necessary
o identify patients with normal pulmonary artery size and
levated PAP. The results showed that:
clinical signs identiﬁed only aminority of patients in whom
TCPC was contraindicated;
echocardiography allowed measurement of pulmonary
artery size in a minority of patients, although it identiﬁed
all patients in whom TCPC was contraindicated because
of ventricular dysfunction;
PAP was elevated in a subgroup of patients with normal
pulmonary artery size and associated antegrade or retro-
grade PBF;
interventional catheterization was often needed in
patients with associated retrograde ﬂow, mostly to
occlude associated sources of PBF.
Patients with cyanotic heart disease invariably have
educed exercise tolerance [11] and are at risk of cerebral
mbolism, due to increased blood viscosity and clot forma-
ion [12]. Thus, completion of cavopulmonary connection
s advocated by most authors, whenever possible. Patients
ith PCPC are a heterogeneous population because of the
ossible presence of additional ﬂow to the lungs.
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Although many authors do not agree with this policy [13],
ome surgeons of the French school often prefer to add or
reserve additional PBF, in order to maintain systemic satu-
ation around 80% and perform TCPC at an older age. Thus,
n our series, TCPC was performed in relatively old patients,
ostly when there was at least one source of retrograde PBF.
As previously shown, we conﬁrmed that additional PBF
revents the decrease of pulmonary artery size observed
fter PCPC [2,14]. Maintaining pulsatile pulmonary ﬂow and
dequate total pulmonary perfusion might promote pul-
onary artery growth [15]. It has been suggested that, in
he absence of additional ﬂow, TCPC should be performed
arly after PCPC to prevent excessive decrease of the Nakata
ndex [14]. However, several reports describe potential dis-
dvantages of additional sources of PBF. BT shunt promotes
istortion and/or stenosis of pulmonary arteries and requires
econstruction of the vessels at the time of PCPC or before
CPC [16]. In our series, three out of 38 patients with BT
hunt underwent pulmonary artery repair. Antegrade pul-
atile ﬂow promotes pulmonary artery growth [15]; however,
t could prompt the development of pulmonary vascular
bstructive disease and preclude TCPC [16].
We conﬁrmed that patients with additional antegrade
ow have larger pulmonary arteries and found increased PAP
n a subgroup of patients with antegrade PBF and normal
akata index. As previously reported, we also observed pul-
onary artery distortion in patients with pulmonary banding
two out of 18 in our series) or interposition of a conduit
etween the single ventricle and the pulmonary arteries
17].
High-quality imaging of pulmonary arteries in PCPC
atients is mandatory before TCPC. Non-invasive imaging
f pulmonary arteries using multislice CT or magnetic res-
nance imaging allows a precise deﬁnition of pulmonary
rtery size and of associated anomalies [18,19]. However, at
he time of this study, we could measure pulmonary artery
ize only using echocardiography and angiography. We con-
rmed that echocardiography is not appropriate to visualize
ulmonary artery size in patients with PCPC [19].
Although we found normal PAP in all but one patient with
ormal Nakata index and isolated PCPC, we found elevated
AP in a subgroup of patients with associated PBF and normal
ulmonary artery size. Thus, correct imaging of pulmonary
rteries could be insufﬁcient to authorize TCPC in a subgroup
f patients.
We believe that high-quality non-invasive imaging of pul-
onary arteries associated with clinical evaluation could
void cardiac catheterization in patients with isolated PCPC
ut not in those with additional sources of PBF. A prospec-
ive study in patients scheduled for TCPC is ongoing in our
nstitution to evaluate the information provided by car-
iac catheterization and CT scan. At present, measurement
f PAP with non-invasive methods remains experimental
20].
Apart from information concerning pulmonary artery
natomy and PAP, a relevant percentage of our patients
ith PCPC needed interventional catheterization to treat
esidual aortic coarctation, dilate pulmonary arteries and
uppress additional sources of PBF. Preoperative closure of
T shunt or patent ductus arteriosus, although potentially
ccompanied by a decrease of systemic saturation, avoids
ncontrolled bleeding during TCPC.H.O. Ba et al.
Preoperative PAP is not a predictor of complicated post-
perative outcome [17]. We conﬁrmed these results and
uppose that the lack of correlation is due to the fact
hat patients with elevated PAP were not considered can-
idates for TCPC. Similarly, we conﬁrmed that pulmonary
rtery size, depressed ejection fraction and AV valve regur-
itation, well-known risk factors inﬂuencing early and late
ortality after TCPC [9], were not predictors of postoper-
tive complications in our series, probably due to patient
election.
tudy limitations
lthough the study population was relatively large, the
ajority of our patients had associated sources of ante-
rade or retrograde ﬂow to the lungs. Thus, the difference
etween groups rarely reached statistical signiﬁcance. Dur-
ng the study period, non-invasive imaging of pulmonary
rteries was not performed systematically.
onclusion
ardiac catheterization is still recommended before TCPC,
ostly in patients with additional PBF, to identify patients
ith high PAP and those needing interventional catheteriza-
ion. The comparison between the information provided by
ardiac catheterization and CT scan will be the object of a
uture study.
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